Projects per year
Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.
- 13 Similar Profiles
Blood-Brain Barrier
Medicine & Life Sciences
Brain Neoplasms
Medicine & Life Sciences
Drug Therapy
Medicine & Life Sciences
Brain
Medicine & Life Sciences
Central Nervous System
Medicine & Life Sciences
Ferrosoferric Oxide
Medicine & Life Sciences
Lymphoma
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 1976 2021
Blood-Brain Barrier
Antineoplastic Agents
Drug Therapy
Cisplatin
Neoplasms
Chemoprotection and imaging for aminoglycoside and chemotherapy toxicities
Project: Research project
Lung Neoplasms
Neoplasm Metastasis
temozolomide
Brain Neoplasms
Blood Volume
Nanoparticle MR Imaging of BBB Inflammation at High Tesla in CNS Tumors
1/19/07 → 12/31/11
Project: Research project
Nanoparticles
Magnetic Resonance Imaging
Inflammation
Ferrosoferric Oxide
Blood Vessels
Blood-Brain Barrier
Brain Neoplasms
Research Personnel
Research
Clinical Protocols
Research Output 1971 2019
Combined iron oxide nanoparticle ferumoxytol and gadolinium contrast enhanced MRI define glioblastoma pseudoprogression
Barajas, R., Hamilton, B., Schwartz, D., Mcconnell, H. L., Pettersson, D., Horvath, A., Szidonya, L., Varallyay, C. G., Firkins, J., Jaboin, J., Kubicky, C. D., Raslan, A., Dogan, A., Cetas, J., Ciporen, J., Han, S. J., Ambady, P., Muldoon, L., Woltjer, R. R., Rooney, W. & 1 others, Mar 18 2019, In : Neuro-Oncology. 21, 4, p. 517-526 10 p.Research output: Contribution to journal › Article
Open Access
Ferrosoferric Oxide
Gadolinium
Glioblastoma
Nanoparticles
Isocitrate Dehydrogenase
Blood-Brain Barrier Disruption Chemotherapy
McGregor, J. M., Bell, S. D., Doolittle, N., Murillo, T. P. & Neuwelt, E., Apr 24 2018, Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy: Second Edition. Elsevier Inc., p. 145-153 9 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter
Blood-Brain Barrier
Drug Therapy
Central Nervous System
Oligodendroglioma
Brain Neoplasms
1
Citation
(Scopus)
Cerebral blood volume mapping with ferumoxytol in dynamic susceptibility contrast perfusion MRI: Comparison to standard of care
Varallyay, C. G., Nesbit, E., Horvath, A., Varallyay, P., Fu, R. R., Gahramanov, S., Muldoon, L., Li, X., Rooney, W. & Neuwelt, E., Jan 1 2018, (Accepted/In press) In : Journal of Magnetic Resonance Imaging.Research output: Contribution to journal › Article
Ferrosoferric Oxide
Standard of Care
Perfusion
Noise
Putamen
Combination immunotherapy as a non-chemotherapy alternative for refractory or recurrent CNS lymphoma
Ambady, P., Szidonya, L., Firkins, J., James, J., Johansson, K., White, T., Jezierski, C., Doolittle, N. & Neuwelt, E., Jan 1 2018, (Accepted/In press) In : Leukemia and Lymphoma.Research output: Contribution to journal › Article
Immunotherapy
Lymphoma
16
Citations
(Scopus)
Sodium thiosulfate for protection from cisplatin-induced hearing loss
Brock, P. R., Maibach, R., Childs, M., Rajput, K., Roebuck, D., Sullivan, M. J., Laithier, V., Ronghe, M., Dall'Igna, P., Hiyama, E., Brichard, B., Skeen, J., Mateos, M. E., Capra, M., Rangaswami, A. A., Ansari, M., Rechnitzer, C., Veal, G. J., Covezzoli, A., Brugières, L. & 4 others, Jun 21 2018, In : New England Journal of Medicine. 378, 25, p. 2376-2385 10 p.Research output: Contribution to journal › Article
Hearing Loss
Cisplatin
Hepatoblastoma
Disease-Free Survival
Confidence Intervals